Schroder Investment Management Group Meridian Bioscience Inc Transaction History

Schroder Investment Management Group

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $182,138 - $541,073	-23,232 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $4,483 - $9,257	805 Added 3.59%	23,232 $206,000
Q4 2019 Feb 11, 2020	BUY	$7.9 - $10.14 $13,667 - $17,542	1,730 Added 8.36%	22,427 $219,000
Q3 2019 Nov 12, 2019	SELL	$9.17 - $12.01 $14,525 - $19,023	-1,584 Reduced 7.11%	20,697 $196,000
Q2 2019 Aug 08, 2019	SELL	$10.88 - $17.6 $141,690 - $229,204	-13,023 Reduced 36.89%	22,281 $265,000
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $49,027 - $55,665	3,161 Added 9.83%	35,304 $622,000
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $53,622 - $72,825	-3,693 Reduced 10.31%	32,143 $558,000
Q3 2018 Nov 13, 2018	SELL	$14.85 - $16.35 $149,435 - $164,530	-10,063 Reduced 21.92%	35,836 $534,000
Q2 2018 Aug 13, 2018	SELL	$13.8 - $16.8 $100,422 - $122,253	-7,277 Reduced 13.68%	45,899 $732,000
Q1 2018 May 11, 2018	BUY	$13.8 - $16.2 $58,360 - $68,509	4,229 Added 8.64%	53,176 $755,000
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $146,854 - $171,240	10,838 Added 28.44%	48,947 $685,000
Q3 2017 Nov 09, 2017	BUY	$13.45 - $14.35 $512,566 - $546,864	38,109	38,109 $541,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.